Marre, Michel
Inserm · Université Paris Cité · Institut Necker Enfants Malades · Clinique Ambroise Paré
37 papers on CoChatORCID 0000-0002-3071-1837
Most cited papers
- Verified
Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
Velho, G., Bouby, N., Hadjadj, S., Matallah, N., Mohammedi, K., Fumeron, F., Potier, L., Bellili-Munoz, N., Taveau, C., Alhenc-Gelas, F., et al. (2013) · Diabetes Care
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 89
- Verified
The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus
Blomster, J. I., Chow, C. K., Zoungas, S., Woodward, M., Patel, A., Poulter, N. R., Marre, M., Harrap, S., Chalmers, J., & Hillis, G. S. (2013) · Diabetes, Obesity and Metabolism
Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 86
- Verified
Factors associated with weight gain in people with type 2 diabetes starting on insulin
Balkau, B., Home, P. D., Vincent, M., Marre, M., & Freemantle, N. (2014) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 77
- Verified
The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: results from the ADVANCE trial
Nguyen, T. N., Harris, K., Woodward, M., Chalmers, J., Cooper, M., Hamet, P., Harrap, S., Heller, S., MacMahon, S., Mancia, G., et al. (2021) · Diabetes Care
Diabetes Treatment and ManagementFrailty in Older Adults
Cited by 72
- Verified
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events
Lingvay, I., Hansen, T., Macura, S., Marre, M., Nauck, M. A., de la Rosa, R., Woo, V., Yildirim, E., & Wilding, J. (2020) · BMJ Open Diabetes Research & Care
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 71
- Verified
The expression of genes in top obesity-associated loci is enriched in insula and substantia nigra brain regions involved in addiction and reward
Ndiaye, F. K., Huyvaert, M., Ortalli, A., Canouil, M., Lecoeur, C., Verbanck, M., Lobbens, S., Khamis, A., Marselli, L., Marchetti, P., et al. (2020) · International Journal of Obesity
Genetic Associations and EpidemiologyNutrition, Genetics, and Disease
Cited by 66
- Verified
Plasma Extracellular Superoxide Dismutase Concentration, Allelic Variations in the SOD3 Gene and Risk of Myocardial Infarction and All-Cause Mortality in People with Type 1 and Type 2 Diabetes
Mohammedi, K., Bellili-Muñoz, N., Marklund, S. L., Driss, F., Le Nagard, H., Patente, T. A., Fumeron, F., Roussel, R., Hadjadj, S., Marre, M., et al. (2015) · Cardiovascular Diabetology
Glutathione Transferases and PolymorphismsParaoxonase enzyme and polymorphisms
Cited by 63
- Verified
Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity
Gao, W., Liu, L., Huh, E., Gbahou, F., Cecon, E., Oshima, M., Houzé, L., Katsonis, P., Hegron, A., Fan, Z., et al. (2023) · Nature Metabolism
Diabetes Treatment and ManagementPancreatic function and diabetes
Cited by 56
- Verified
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial
Ohkuma, T., Jun, M., Rodgers, A., Cooper, M. E., Glasziou, P., Hamet, P., Harrap, S., Mancia, G., Marre, M., Neal, B., et al. (2019) · Hypertension
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 56
- Verified
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
Rahman, F., McEvoy, J. W., Ohkuma, T., Marre, M., Hamet, P., Harrap, S., Mancia, G., Rodgers, A., Selvin, E., Williams, B., et al. (2019) · Hypertension
Blood Pressure and Hypertension StudiesDiabetes Treatment and Management
Cited by 48
- Verified
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings
Guerci, B., Charbonnel, B., Gourdy, P., Hadjadj, S., Hanaire, H., Marre, M., & Vergès, B. (2019) · Diabetes & Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 40
- Verified
Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
Duesing, K., Fatemifar, G., Charpentier, G., Marre, M., Tichet, J., Hercberg, S., Balkau, B., Froguel, P., & Gibson, F. (2008) · Diabetes
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 35
- Verified
Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study
for the SURDIAGENE Study Group, Fraty, M., Velho, G., Gand, E., Fumeron, F., Ragot, S., Sosner, P., Mohammedi, K., Gellen, B., Saulnier, P.-J., et al. (2018) · Diabetologia
Heart Failure Treatment and ManagementGDF15 and Related Biomarkers
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free